News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Clarity Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health & Biotech
Health Check: EBOS Group’s earnings surge – or plunge – but bottom line is, pharmacies are in rude health
News
ASX Lunch Wrap: ASX edges up on Wall Street’s record high, as Trump’s oil push stirs markets
Health & Biotech
Health Check: Local biotech starred in 2024, but the rising tide did not lift all boats
Health & Biotech
ASX healthcare 2024 winners and losers, plus what’s next for 2025
Health & Biotech
Stocking stuffers: Morgans’ top ASX health picks for 2025
Experts
Hot Money Monday: Bell Potter backs these tech and healthcare stocks for 2025
News
ASX Lunch Wrap: ASX higher ahead of Fed; MinRes completes $780m gas deal with Rinehart
Health & Biotech
Health Check: Can Syntara produce the next multibillion-dollar Aussie blood cancer drug?
Health & Biotech
Health Check: Booming Sonic seals a $700 million German acquisition
Health & Biotech
Health Check: Painchek strives to Make American Aged Folk Comfortable Again
Health & Biotech
October Health Winners: Uscom, Respiri lead sluggish sector, but ‘time in the market, not timing, is key’
Health & Biotech
Health Check: Nuclear medicine stocks tipped to glow after favourable US decision
Health & Biotech
Health Check: Thirsty Chimeric goes to the well for funding top-up
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall but there’s ‘wind in the sails again’
Health & Biotech
Alive and Kicking: Prescient Therapeutics chief passes CEO baton after eight years in the job
News
ASX Rebalance: Copper in, lithium out as hot biotechs climb ranks
News
